SomnoMed Limited (SOMNF)
SOMNF Stock Price Chart
Explore SomnoMed Limited interactive price chart. Choose custom timeframes to analyze SOMNF price movements and trends.
SOMNF Company Profile
Discover essential business fundamentals and corporate details for SomnoMed Limited (SOMNF) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Devices
IPO Date
15 Oct 2010
Employees
—
Website
https://somnomed.comCEO
Amrita Blickstead BME,
Description
SomnoMed Limited, together with its subsidiaries, engages in the production and sale of devices for the oral treatment of sleep related disorders in Europe, North America, and the Asia Pacific region. It offers SomnoDent, an oral appliance for obstructive sleep apnea; SomnoBrux, a dental guard for the treatment of teeth grinding damage; SomMorning Repositioner, which help return mandible back to its pre-treatment centric position; and SomTabs for cleaning oral devices. The company was incorporated in 1987 and is headquartered in Crows Nest, Australia.
SOMNF Financial Timeline
Browse a chronological timeline of SomnoMed Limited corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 25 Feb 2026
Upcoming earnings on 25 Feb 2026
Earnings released on 27 Aug 2025
EPS came in at -$0.00 falling short of the estimated $0.00 by -249.24%, while revenue for the quarter reached $38.01M , beating expectations by +6.06%.
Earnings released on 21 Jul 2025
Earnings released on 26 Feb 2025
EPS came in at -$0.03 falling short of the estimated $0.00 by -5.09K%, while revenue for the quarter reached $33.22M , meeting expectations.
Earnings released on 22 Oct 2024
Earnings released on 23 Jul 2024
EPS came in at -$0.03 falling short of the estimated -$0.00 by -1.53K%, while revenue for the quarter reached $15.51M , missing expectations by -49.95%.
Earnings released on 29 Apr 2024
EPS came in at -$0.01 , while revenue for the quarter reached $15.10M .
Earnings released on 28 Feb 2024
EPS came in at -$0.04 falling short of the estimated -$0.01 by -239.37%, while revenue for the quarter reached $30.71M , beating expectations by +2.54%.
Earnings released on 29 Jan 2024
EPS came in at -$0.02 , while revenue for the quarter reached $14.44M .
Stock split effective on 21 Sept 2023
Shares were split 209 : 200 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 30 Jun 2023
EPS came in at -$0.04 , while revenue for the quarter reached $28.99M .
Earnings released on 31 Mar 2023
EPS came in at -$0.02 falling short of the estimated -$0.01 by -80.32%, while revenue for the quarter reached $14.66M , missing expectations by -50.54%.
Earnings released on 30 Dec 2022
EPS came in at -$0.03 , while revenue for the quarter reached $27.31M .
Earnings released on 30 Sept 2022
EPS came in at -$0.02 surpassing the estimated -$0.02 by +22.27%, while revenue for the quarter reached $12.95M , missing expectations by -54.76%.
Earnings released on 30 Jun 2022
EPS came in at -$0.01 , while revenue for the quarter reached $26.57M .
Earnings released on 31 Mar 2022
EPS came in at -$0.01 surpassing the estimated -$0.01 by +37.31%, while revenue for the quarter reached $14.50M , missing expectations by -45.00%.
Earnings released on 30 Dec 2021
EPS came in at -$0.03 , while revenue for the quarter reached $24.60M .
Earnings released on 30 Sept 2021
EPS came in at -$0.01 falling short of the estimated -$0.01 by -40.68%, while revenue for the quarter reached $12.28M , missing expectations by -52.99%.
Earnings released on 30 Jun 2021
EPS came in at -$0.01 , while revenue for the quarter reached $23.94M .
Earnings released on 31 Mar 2021
EPS came in at -$0.01 falling short of the estimated $0.01 by -173.27%, while revenue for the quarter reached $12.14M , missing expectations by -52.45%.
Earnings released on 30 Dec 2020
EPS came in at $0.00 , while revenue for the quarter reached $23.64M .
Earnings released on 30 Sept 2020
EPS came in at $0.00 surpassing the estimated -$0.01 by +150.39%, while revenue for the quarter reached $11.04M , missing expectations by -50.65%.
SOMNF Stock Performance
Access detailed SOMNF performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.